Related Experiment Video

Updated: Aug 17, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Pathophysiology and treatment of the anemia of prematurity

D Attias1

  • 1Pediatric Hemotology/Oncology Unit, Bnai Zion Medical Center, Technion, Israel.

Journal of Pediatric Hematology/Oncology
|February 1, 1995
PubMed

Insights

Low erythropoietin (Epo) levels cause anemia of prematurity (AOP). Epo administration effectively treats AOP, reducing or eliminating the need for blood transfusions in premature infants.

Area of Science:

  • Neonatology
  • Hematology
  • Pediatric Medicine

Background:

  • Anemia of prematurity (AOP) is a common complication in premature infants.
  • The pathophysiology of AOP has been increasingly elucidated.
  • Low endogenous erythropoietin (Epo) levels are recognized as a primary factor in AOP.

Purpose of the Study:

  • To investigate the role of erythropoietin (Epo) in the pathophysiology of anemia of prematurity (AOP).
  • To evaluate the therapeutic efficacy of Epo administration for AOP.

Main Methods:

  • Review of current understanding of AOP pathophysiology.
  • Analysis of the impact of Epo administration on AOP symptoms and transfusion requirements.

Main Results:

  • Epo deficiency is the basis for anemia of prematurity.
  • Epo administration effectively treats AOP.
  • Epo therapy can significantly reduce or prevent the need for blood transfusions.

Conclusions:

  • Understanding the pathophysiology of AOP has led to effective treatments.
  • Erythropoietin (Epo) is a key therapeutic agent for managing anemia of prematurity.
  • Epo administration offers a viable alternative to blood transfusions in premature infants.

More Related Videos

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...